7,8 Although the findings of these prior studies help to inform shared decision-making about treatment of advanced CKD, they are restricted to studies comparing groups treated with dialysis and those treated conservatively. As a result, prior systematic reviews and meta-analyses reflect only a ...
These biomarkers were chosen based on 1) established biological importance in disease processes of interest (inflammation, ischemia, fibrosis, oxidative stress and vascular health), 2) robust evidence of association with clinical outcomes, and 3) commercial availability of assays [17–35]. Importantly...